Cargando…

Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis

Psoriasis is immune-mediated skin disorder affecting thousands of people. Sphingolipids (SLs) are bioactive molecules present in the epidermis, involved in the following cellular processes: proliferation, differentiation, and apoptosis of keratinocytes. Alterations in SLs synthesis have been observe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burger, Beatriz, Sagiorato, Roberta Nicolli, Cavenaghi, Isabella, Rodrigues, Hosana Gomes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968075/ https://www.ncbi.nlm.nih.gov/pubmed/36837912 http://dx.doi.org/10.3390/metabo13020291

Ejemplares similares

Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis
por: Bocheńska, Katarzyna, et al.
Publicado: (2020)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

Abnormal islet sphingolipid metabolism in type 1 diabetes
por: Holm, Laurits J., et al.
Publicado: (2018)

Crosstalk between Serum and Skin Sphingolipids in Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
por: Quinville, Brianna M., et al.
Publicado: (2021)

Plasma sphingolipid abnormalities in neurodegenerative diseases
por: Oizumi, Hideki, et al.
Publicado: (2022)

Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
por: Merrill, Alfred H.
Publicado: (2011)

Gene Therapy of Sphingolipid Metabolic Disorders
por: Shaimardanova, Alisa A., et al.
Publicado: (2023)

Sphingolipids in cardiovascular diseases and metabolic disorders
por: Borodzicz, Sonia, et al.
Publicado: (2015)

Colon Cancer and Perturbations of the Sphingolipid Metabolism
por: Machala, Miroslav, et al.
Publicado: (2019)

The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia
por: Thomas, Jaya M., et al.
Publicado: (2022)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Psoriasis Pathogenesis and Treatment
por: Rendon, Adriana, et al.
Publicado: (2019)

Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti‐neutral glycolipid antibody
por: Mutoh, Tatsuro, et al.
Publicado: (2023)

Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Sphingolipid Metabolic Pathway: An Overview of Major Roles Played in Human Diseases
por: Pralhada Rao, Raghavendra, et al.
Publicado: (2013)

Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer’s Disease
por: Qi, Yi-Yu, et al.
Publicado: (2022)

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
por: Don, Anthony S., et al.
Publicado: (2014)

Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation
por: Norris, Gregory H., et al.
Publicado: (2017)

Translational Aspects of Sphingolipid Metabolism in Renal Disorders
por: Abou Daher, Alaa, et al.
Publicado: (2017)

New Insights into the Role of Sphingolipid Metabolism in Melanoma
por: Carrié, Lorry, et al.
Publicado: (2020)

Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
por: Parveen, Farzana, et al.
Publicado: (2019)

Effects of sphingolipid metabolism disorders on endothelial cells
por: Lai, Yali, et al.
Publicado: (2022)

Abnormal Sphingolipid World in Inflammation Specific for Lysosomal Storage Diseases and Skin Disorders
por: Moskot, Marta, et al.
Publicado: (2018)

The Role of Adipokines in the Pathogenesis of Psoriasis
por: Kiełbowski, Kajetan, et al.
Publicado: (2023)

The Role of Sirtuins in the Pathogenesis of Psoriasis
por: Słuczanowska-Głabowska, Sylwia, et al.
Publicado: (2023)

Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage
por: Khan, Saad A., et al.
Publicado: (2021)

Functions of Sphingolipids in Pathogenesis During Host–Pathogen Interactions
por: Wang, Jian, et al.
Publicado: (2021)

New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
por: Ventura, Alessandra, et al.
Publicado: (2017)

An Introduction to Sphingolipid Metabolism and Analysis by New Technologies
por: Chen, Yanfeng, et al.
Publicado: (2010)

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019)

Diversity in sphingolipid metabolism across land plants
por: Haslam, Tegan M, et al.
Publicado: (2022)

Eicosapentaenoic acid-rich oil supplementation activates PPAR-γ and delays skin wound healing in type 1 diabetic mice
por: Burger, Beatriz, et al.
Publicado: (2023)

Sphingolipids in COPD
por: Chakinala, Raja Chandra, et al.
Publicado: (2019)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020)

Computational modeling of sphingolipid metabolism
por: Wronowska, Weronika, et al.
Publicado: (2015)

Autophagy in the light of sphingolipid metabolism
por: Harvald, Eva Bang, et al.
Publicado: (2015)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Sphingolipid Metabolism in Systemic Inflammation
por: Deigner, H. P., et al.
Publicado: (2007)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3iq0091l2qg19l6udq0fut09n